123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with cororectal cancer

British Journal of Cancer

Volumn 78, Issue 1, 1998, Pages 1-5

  Raderer, M ^a   Kurtaran, A ^a   Hejna, M ^a   Vorbeck, F ^a   Angelberger, P ^b   Scheithauer, W ^a   Virgolini, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

Colorectal cancer; Imaging; Vasoactive intestinal peptide

Indexed keywords

IODINE 123; RADIOLIGAND; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MEDICINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; COLON TUMOR; METHODOLOGY; MIDDLE AGED; RECTUM TUMOR; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RECTAL NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0031595739     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.433     Document Type: Article

References (16)

1. Boring CC, Squires TS, Tong T and Montgomery S (1994) Cancer statistics 1994. CA Cancer L Clin 44: 7-26
2. DeCosse JJ, Tsoulias GJ and Jacobson JS (1994) Colorectal cancer: detection, treatment and rehabilitation. CA Cancer J Clin 44: 27-42
3. Kintzler K, Nilbert M, Su L, et al (1991) Identification of FAP gene locus genes from chromosome 5q21. Science 253: 661-665
4. Patt YZ, Podoloff DA, Curley S, et al (1994) Technetium-99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult disease in patients with rising serum carcinoembryonic antigen levels. J Clin Oncol 12: 489-495
5. Peltomäki P, Aaltonen LA, Sistonen P, et al (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260: 812-816
6. Raderer M, Becherer A, Kurtaran A, et al (1996) Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy. J Nucl Med 37: 1480-1487
7. 123I]Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic cancer: a novel tool in the diagnostic armamentarium. J Nucl Med (in press)
8. Reubi JC (1995) In vitro identification of vasoactive intestinal peptide receptors on human tumours: implications for tumor imaging. J Nucl Med 36: 1846-1853
9. Rutgers EJ (1995) Radio-immunotargeting in colorectal carcinomas. Eur J Cancer 31A: 1243-1247
10. Scheithauer W, Rosen H, Kornek GV, et al (1993) Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer. Br Med J 306: 752-755
11. Schlag P, Lehner B, Strauss LG, et al (1989) Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy. Arch Surg 124: 197-200
12. Seidman H, Mushnick MH, Gelb SK and Silverberg E (1985) Probability of eventually developing or dying of cancer: United States. CA Cancer J Clin 35: 36-56
13. Stevenson G (1995) Radiology in the detection and prevention of colorectal cancer. Eur J Cancer 31A: 1121-1126
14. Virgolini I, Yang Q, Li SR et al (1994a) Cross competition between vasoactive intestinal peptide (VIP) and somatostatin for binding to tumor cell receptors. Cancer Res 54: 690-700
15. Virgolini I, Raderer M, Kurtaran A. et al (1994b) Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N Engl J Med 331: 1116-1121
16. Virgolini I, Kurturan A, Raderer M, et al (1995) Vasoactive intestinal peptide receptor scintigraphy. J Nucl Med 36: 1732-1739